Health Care

Hawley Sends Letter to Pentagon & Defense Health Agency Advocating for Fort Leonard Wood’s Community Hospital

Thursday, July 10, 2025

Today, U.S. Senator Josh Hawley (R-Mo.) sent a letter to acting Assistant Secretary of Defense for Health Affairs Dr. Stephen Ferrara and Acting Director of the Defense Health Agency (DHA) Dr. David J. Smith, urging them to protect Fort Leonard Wood’s newly built hospital, the General Leonard Wood Army Community Hospital (GLWACH). Senator Hawley wrote, “In recent weeks, members of my staff have received credible reports that DHA continues to consider major changes to the resourcing of GLWACH....

read more

Hawley Passes RECA, Secures New Medicaid Funding in Senate Reconciliation Bill

Tuesday, July 01, 2025

Vows to Fight Future Medicaid Cuts U.S. Senator Josh Hawley (R-Mo.) secured the largest expansion ever to the Radiation Exposure Compensation Act (RECA) as well as new funding for Medicaid as part of the “One Big, Beautiful Bill” that passed the Senate today. Senator Hawley supported the legislation after negotiating the inclusion of these key Missouri priorities. Senator Hawley’s RECA provision will deliver long-overdue compensation and health care for survivors of radiation-linked cancers in...

read more

Hawley, Hassan, Kelly Reintroduce Bipartisan Bill to Strengthen Rural Hospital Cybersecurity

Wednesday, June 25, 2025

Today, U.S. Senators Josh Hawley (R-Mo.), Maggie Hassan (D-N.H.), and Mark Kelly (D-Ariz.) reintroduced the Rural Hospital Cybersecurity Enhancement Act, which directs the Department of Health and Human Services (HHS) to develop a comprehensive strategy to address the growing need for skilled cybersecurity professionals in rural hospitals. The strategy aims to improve cybersecurity preparedness and create a robust workforce to protect vulnerable critical infrastructure—rural...

read more

Hawley, Shaheen Introduce Legislation to End Taxpayer-Funded Pharma Ads

Thursday, May 15, 2025

Today, U.S. Senators Josh Hawley (R-Mo.) and Jeanne Shaheen (D-N.H.) introduced the No Handouts for Drug Advertisements Act, which would end federal subsidies for pharmaceutical company advertising. Current law allows pharmaceutical companies to claim business deductions on direct-to-consumer advertising, subsidizing their publicity at taxpayers’ expense. Direct-to-consumer advertising contributes to increased healthcare costs and encourages patients to request specific brand-name...

read more

Hawley Secures Pledge from RFK to Review ‘Alarming’ Mifepristone Data, Support Bill Cracking Down on Big Pharma Ads

Wednesday, May 14, 2025

Today in a Senate Health, Education, Labor and Pensions Committee hearing, U.S. Senator Josh Hawley (R-Mo.) secured a commitment from Health and Human Services Secretary Robert F. Kennedy (RFK) Jr. that he would review ‘alarming’ new data on the chemical abortion drug mifepristone. RFK Jr. also stated that in light of the new data, the Food and Drug Administration (FDA) label for mifepristone should change to accurately reflect the adverse effects of the drug....

read more

Hawley Blasts Pharmacy Benefit Managers for ‘Screwing’ Patients, Calls for Breaking Up ‘Pharma Monopoly’

Tuesday, May 13, 2025

Today, U.S. Senator Josh Hawley (R-Mo.) blasted pharmacy benefit managers (PBMs) for raising drug prices and profiting at the expense of Missourians.  https://twitter.com/HawleyMO/status/1922327186574327897 Senator Hawley grilled Pharmaceutical Care Management Association (PCMA) President J.C. Scott, questioning why Americans pay 422% more than other countries for the same brand name prescription drugs. “You’re supposed to be making drugs more affordable for consumers – would you say that you...

read more

Hawley Statement in Support of Reining in Prescription Drug Prices

Monday, May 12, 2025

Today U.S. Senator Josh Hawley (R-Mo.) released the following statement in support of President Trump's executive order to lower prescription drug prices. Last week, Senator Hawley introduced the bipartisan Fair Prescription Drug Prices for Americans Act, which would offer relief for millions of patients while ensuring Americans are no longer financing lower drug costs for foreigners. https://twitter.com/HawleyMO/status/1921950612104601836

read more

Hawley Op-Ed: Don’t Cut Medicaid

Monday, May 12, 2025

By U.S. Senator Josh Hawley (R-Mo.) | May 12, 2025 | The New York Times Polls show Democrats down in the dumps at their lowest approval level in decades, but we Republicans are having an identity crisis of our own, and you can see it in the tug of war over President Trump’s “one big, beautiful bill.” The nub of the conflict: Will Republicans be a majority party of working people, or a permanent minority speaking only for the C suite?Mr. Trump has promised working-class tax cuts and protection...

read more

Hawley Secures Commitment from RFK’s Deputy Nominee to Review Chemical Abortion Data

Thursday, May 08, 2025

Today in a hearing in the Senate Committee on Health, Education, Labor and Pensions, U.S. Senator Josh Hawley (R-Mo.) secured a commitment from Jim O’Neill – President Trump’s nominee to serve as Deputy Secretary of Health and Human Services – to conduct an updated safety review on the chemical abortion drug mifepristone if he were confirmed. The promise comes on the heels of a new study showing that 1 in 10 women who take the drug suffer from adverse health effects.O’Neill agreed with Senator...

read more

Hawley Introduces Legislation to Reinstate Safety Regulations on Chemical Abortion Drug Mifepristone

Tuesday, May 06, 2025

Today, U.S. Senator Josh Hawley (R-Mo.) introduced the Restoring Safeguards for Dangerous Abortion Drugs Act to reinstate safety regulations on the chemical abortion drug mifepristone. The legislation comes after a recent study revealed 1 in 10 women who take the drug experience adverse health effects. “I’m introducing the Restoring Safeguards for Dangerous Abortion Drugs Act after a bombshell study revealed the truth about mifepristone: it’s...

read more